Irbesartan 300mg film-coated tablets - blisters is incorrectly labelled as Irbesartan 150mg

(Accord Healthcare Limited) Recipients should quarantine any remaining stock and return it to supplier for credit - class 2 action within 48 hours. (EL (13)A/32)

23 December 2013

Class 2 medicines recall

Action within 48 hours

Class 2 medicines recall

Pharmacy, dispensing clinic and wholesale-level recall

MDR 30-12/13

Product details

Accord Healthcare Limited

Irbesartan 300mg Film-coated Tablets

PL 20075/0354

Alert details

Batch number   Expiry date   Pack size   First distributed
P02924   January 2015   2 X 14’s   11 September 2013

Accord Healthcare Limited is recalling the above batch of Irbesartan 300mg film-coated tablets because the blister foil on a small number of blisters is incorrectly labelled as Irbesartan 150mg. All other labelling is correct and tablets present in the blisters are 300mg strength.

Recipients are requested to quarantine any remaining stock and return it to their supplier for credit.

For stock return enquiries, please contact Accord Healthcare Limited on 0208 8631 427 or email - customerserviceuk@accord-healthcare.com.

For quality or medical information enquiries, please contact Accord Healthcare Limited on 020 8901 3370 or email - safety@lambda-cro.com and uk@accord-healthcare.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.

Download documents

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.